Braxia Scientific Corp. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-14. The offering totals $5.3M, of which $2.4M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 26 people.
| Name | Role | Location |
|---|---|---|
| David Greenberg | Director | Chicago, IL |
| Kevin Kratiuk | Executive Officer | Toronto, A6 |
| Peter Rizakos | Executive Officer | Toronto, A6 |
| Jerry Habuda | Director | Toronto, A6 |
| Stephen Brooks | Executive Officer | Toronto, A6 |
| Daniel Herrera | Executive Officer | Toronto, A6 |
| Jason Wolkove | Executive Officer | Toronto, A6 |
| Roger McIntyre | Director | Toronto, A6 |
| Roger McIntyre | Executive Officer | Toronto, A6 |
| Joshua Rosenblat | Executive Officer | Toronto, A6 |
| Olga Cwiek | Director | Toronto, A6 |
| Stephen Brohman | Executive Officer | Vancouver, A1 |
| Kevin S Kratiuk | Executive Officer | Toronto, A6 |
| Jerry S Habuda | Director | Toronto, A6 |
| Jason S Wolkove | Executive Officer | Toronto, A6 |
| Peter S Rizakos | Executive Officer | Toronto, A6 |
| Roger S McIntyre | Director | Toronto, A6 |
| Roger S McIntyre | Executive Officer | Toronto, A6 |
| Stephen S Brooks | Executive Officer | Toronto, A6 |
| Olga S Cwiek | Director | Toronto, A6 |
| Joshua S Rosenblat | Executive Officer | Toronto, A6 |
| MATTHEW FISH | Director | VANCOUVER, A1 |
| MATTHEW FISH | Executive Officer | VANCOUVER, A1 |
| Pat McCutcheon | Director | VANCOUVER, A1 |
| Gareth Birdsall | Director | VANCOUVER, A1 |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2024-03-21 | D/A | $730K | $249K |
| 2023-08-23 | D/A | $2.3M | $2.3M |
| 2023-03-24 | D | $730K | $249K |
| 2022-08-22 | D | $2.3M | $2.3M |
| 2020-06-23 | D | $1.6M | $951K |